2027 ICD-10-CM Diagnosis Code T44.3X5SAdverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela

ICD-10-CM Codes›S00–T88›T36-T50›T44

ICD-10-CM T44.3X5S
CMSSource: CMS FY 2027 ICD-10-CM dataset · Effective Oct 1, 2026 – Sep 30, 2027

T44.3X5S is a billable ICD-10-CM diagnosis code for adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela. The 7th character S marks it as a sequela code, which reports a problem that remains after the original condition has resolved. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 922 through 923. The code is not accepted as a principal diagnosis by the Medicare Code Editor and exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Poisoning/toxic effect/adverse effects/underdosing, sequela.

Code Identity

ICD-10-CM Code
T44.3X5S
Billable Status
Yes — Valid for Submission
Code Describes
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
Short Description
Adverse effect of parasympath and spasmolytics, sequela
Parent Code
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT44Poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system
This CodeT44.3X5SAdverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela

Code EditsBilling

Medicare Code Editor checks that affect claim validity for T44.3X5S.

There are selected codes that describe a circumstance which influences an individual's health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.

Present on Admission (POA)Billing

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Adverse reaction to adiphenine
  • Adverse reaction to piperidolate
  • Adverse reaction to smooth muscle relaxant
  • Alverine adverse reaction
  • Anticholinergic adverse reaction
  • Antimuscarinic adverse reaction
  • Atropine adverse reaction
  • Belladonna alkaloids adverse reaction
  • Biperiden adverse reaction
  • Cyclopentolate adverse reaction
  • Dicycloverine adverse reaction
  • Emepronium bromide adverse reaction
  • Flavoxate adverse reaction
  • Glycopyrronium adverse reaction
  • Homatropine adverse reaction
  • Hyoscine adverse reaction
  • Hyoscine butylbromide adverse reaction
  • Hyoscine hydrobromide adverse reaction
  • Mebeverine adverse reaction
  • Mepenzolate adverse reaction
  • Methixene adverse reaction
  • Opium alkaloid adverse reaction
  • Oxybutynin adverse reaction
  • Papaverine adverse reaction
  • Phosphodiesterase inhibitor adverse reaction
  • Pipenzolate adverse reaction
  • Poldine adverse reaction
  • Procyclidine adverse reaction
  • Propantheline adverse reaction
  • Trihexyphenidyl adverse reaction
  • Tropicamide adverse reaction

Coding GuidelinesGuidance

When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system (T44). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027, published by CMS and the National Center for Health Statistics.

Instructional NotesGuidance

Instructions from the official ICD-10-CM Tabular List that apply to T44.3X5S: its own notes plus those printed at T44, block T36-T50, and Chapter 19. A note printed at a category, block or chapter applies to every code under it.

Includes

Further defines, or gives examples of, the content of the category.

From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • adverse effect of correct substance properly administered
  • poisoning by overdose of substance
  • poisoning by wrong substance given or taken in error
  • underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed

Excludes1

Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.

From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • toxic reaction to local anesthesia in pregnancy (O29.3-)

Excludes2

Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.

From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • abuse and dependence of psychoactive substances (F10-F19)
  • abuse of non-dependence-producing substances (F55.-)
  • immunodeficiency due to drugs (D84.821)
  • drug reaction and poisoning affecting newborn (P00-P96)
  • pathological drug intoxication (inebriation) (F10-F19)
From Chapter 19 (S00-T88) Injury, poisoning and certain other consequences of external causes applies to 41,187 codes

Code First

The underlying condition named in the note is sequenced before this code.

From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • for adverse effects, the nature of the adverse effect, such as:
  • adverse effect NOS (T88.7)
  • aspirin gastritis (K29.-)
  • blood disorders (D56-D76)
  • contact dermatitis (L23-L25)
  • dermatitis due to substances taken internally (L27.-)
  • nephropathy (N14.0-N14.2)

Use Additional Code

Add a second code, after this one, to fully describe the condition.

From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • code(s) to specify:
  • manifestations of poisoning
  • underdosing or failure in dosage during medical and surgical care (Y63.6, Y63.8-Y63.9)
  • underdosing of medication regimen (Z91.12-, Z91.13-)
From Chapter 19 (S00-T88) Injury, poisoning and certain other consequences of external causes applies to 41,187 codes
  • code to identify any retained foreign body, if applicable (Z18.-)

Notes

General instructions on how these codes are used.

From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.
From Chapter 19 (S00-T88) Injury, poisoning and certain other consequences of external causes applies to 41,187 codes
  • Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
  • The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.

7th Character

Every code in the category takes a 7th character from the listed values, with the placeholder X filling any empty positions before it.

From T44 Poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system applies to 198 codes
  • The appropriate 7th character is to be added to each code from category T44
  • Ainitial encounter
  • Dsubsequent encounter
  • Ssequela this code

Source: CMS ICD-10-CM Tabular List. How to read instructional notes.

Referenced in Other NotesGuidance

Instructional notes printed at other codes that name T44.3X5S, its category, or a range that includes it.

Excludes1 1

These codes carry an Excludes1 note naming T44.3X5S: they are not reported together with it, unless the two conditions are unrelated.

  • T46.7 Poisoning by, adverse effect of and underdosing of peripheral vasodilators
    poisoning by, adverse effect of and underdosing of papaverine (T44.3) names T44.3, which includes this code

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR INJ075
Poisoning/toxic effect/adverse effects/underdosing, sequela
Default principal diagnosis: inpatient No · outpatient Yes

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect
Under­dosing
AdiphenineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
AlverineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Ambutonium bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
AminopentamideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
AmprotropineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
AniscoropineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Anisotropine methyl-bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Antagonist::extrapyramidal NECT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Anticholinergic NECT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Antimuscarinic NECT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
ArtaneT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
AtropineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Atropine::derivativeT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Atropine::methonitrateT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Belladonna [See Also: Nightshade]::alkaloidsT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Belladonna [See Also: Nightshade]::extractT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Belladonna [See Also: Nightshade]::herbT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
BenactyzineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
BenaprizineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
BenzhexolT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Benzilonium bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Benztropine::anticholinergicT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Bevonium metilsulfateT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
BiperidenT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
BornaprineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
ButethamateT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Butropium bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Butyl::scopolamine bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
CamylofinT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
CaramiphenT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Carpronium chlorideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
ChlorbenzoxamineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Cimetropium bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Clidinium bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
ClorotepineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
CogentinT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
CyclodrineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
CyclopentolateT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
CycrimineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
DexetimideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Dibutoline sulfateT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
DicyclomineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
DicycloverineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
DiisopromineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
DiphemanilT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Diphemanil::metilsulfateT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
DrotaverineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
DuboisineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
DyphyllineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Emepronium (salts)T44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Emepronium (salts)::bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
EthaverineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
EthopropazineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
EtomidolineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
EtybenzatropineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
EuphthalmineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Extrapyramidal antagonist NECT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
FenoverineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
FlavoxateT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
FlopropioneT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
GefarnateT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
GlycopyrrolateT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
GlycopyrroniumT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Glycopyrronium::bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Hexasonium iodideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
HexocycliumT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Hexocyclium::metilsulfateT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
HomatropineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Homatropine::methylbromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
HyoscineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
HyoscyamineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
HyoscyamusT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Hyoscyamus::dry extractT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
IsomethepteneT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
IsopropamideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Isopropamide::iodideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
LevsinT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
MebeverineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
MeladrazineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
MepenzolateT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Mepenzolate::bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
MepiperphenidolT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
MethanthelineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Methanthelinium bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
MethixeneT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Methscopolamine bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Methyl::atropineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Methylatropine nitrateT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Methylbenactyzium bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
MetixeneT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
MilverineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
MoxaverineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Muscle affecting agents NEC::relaxants::smoothT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
MydriacylT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Octatropine methyl-bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Otilonium bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Oxapium iodideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
OxybutyninT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
OxyphencyclimineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Oxyphenonium bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
PapaverineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Parasympatholytic NECT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Penthienate bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
PhenglutarimideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Pinaverium bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Pipenzolate bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
PiperidolateT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
PipethanateT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Poldine metilsulfateT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
PramiverineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
PridinolT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Prifinium bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Pro-BanthineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
ProcyclidineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
ProfenamineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
ProfenilT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
PropanthelineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Propantheline::bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Quarternary ammonium::parasympatholyticT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Relaxant, muscle::smooth NECT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
RociverineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
ScopolamineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Scopolia extractT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Smooth muscle relaxantT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
SpacolineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Spasmolytic::anticholinergicsT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Spasmolytic::autonomicT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Spasmolytic::quaternary ammoniumT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
SulmetozineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
ThiphenamilT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
TiemoniumT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Tiemonium::iodideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
TifenamilT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
TigloidineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Timepidium bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Tiquizium bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
TolperisoneT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
ToquizineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
TrasentineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
TriampyzineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Tricyclamol chlorideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Tridihexethyl iodideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
TrihexyphenidylT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
TrimebutineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Trimeprazine (tartrate)T44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
TriperidenT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
TrithiozineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
TritiozineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
TropacineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
TropatepineT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
TropicamideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Trospium chlorideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6
Valethamate bromideT44.3X1T44.3X2T44.3X3T44.3X4T44.3X5T44.3X6

Patient EducationClinical

Drug Reactions

Most of the time, medicines make our lives better. They reduce aches and pains, fight infections, and control problems such as high blood pressure or diabetes. But medicines can also cause unwanted reactions, such as drug interactions, side effects, and allergies.

The full article covers:

  • What is a drug interaction?
  • What are side effects?
  • What are drug allergies?
  • How can I stay safe when taking medicines?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert T44.3X5S to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
909.5 Lte efct advrs efct drug
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
E941.1 Adv eff parasympatholytc
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2026No changes
FY 2027CurrentCurrent code set, no changesEffective October 1, 2026 through September 30, 2027.

Questions About T44.3X5SOverview

Is T44.3X5S a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

What does the 7th character S in T44.3X5S mean?

The final character S makes this a sequela code: it reports a lingering problem that remains after the adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics itself has resolved, not the original event.

What MS-DRG does T44.3X5S group to?

On inpatient claims, adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela maps to MS-DRG 923, 922, with relative weights from 0.9980 to 1.6248 depending on complications. Higher weights mean higher Medicare reimbursement.

Can T44.3X5S be a principal diagnosis?

No. The Medicare Code Editor rejects this code as a principal diagnosis because adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela describes a circumstance that influences health status rather than a current illness. Report it as a secondary diagnosis.

Is T44.3X5S exempt from POA reporting?

Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela on inpatient claims. The code appears in the Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50) range of the CMS exempt list.